P367Inhibition of STAT3 signaling prevents vascular smooth muscle cell proliferation and neointima formation

    loading  Checking for direct PDF access through Ovid


Dedifferentiation, migration, and proliferation of resident vascular smooth muscle cells (SMCs) are key components of neointima formation after vascular injury. Activationof signal transducer and activator of transcription-3 (STAT3) is suggested to be critically involved in this process, but the complex regulation of STAT3-dependent genes and the functional significance of inhibiting this pathway during the development of vascular proliferative diseases remain elusive. In this study, we demonstrate that STAT3 was activated and up-regulated in the developing neointimal lesions following wire-induced injury in mice. Phosphorylation of STAT3 induced trans-activation of cyclin D1 and survivin in SMCs in vitro and in neointimal cells in vivo, thus promoting proliferation and migration of SMCs as well as reducing apoptotic cell death. WP1066, a highly potent inhibitor of STAT3 signaling, abrogated phosphorylationof STAT3 and dose-dependently inhibited the functional effects of STAT3 in activated SMCs. The local application of WP1066 via a thermosensitive pluronic F-127 gel around the dilated arteries significantly decreased the neointimal lesion size and inhibited proliferation of neoinitmal cells at 3 weeks after injury. Even though WP1066 application attenuated the injury-induced up-regulation of thechemokine RANTES at 6 hours after injury, there was no significant effect on the accumulation of circulating cells at 1 week after injury.

In conclusion, these data identify STAT3 as a key molecule for theproliferative response of SMC and neointima formation. Moreover, inhibition of STAT3 by the potent and specific compound WP1066 might represent a novel and attractive approach for the treatment of vascular proliferative diseases.

Related Topics

    loading  Loading Related Articles